12 Health Care Stocks Moving In Thursday's Pre-Market Session

Benzinga·01/23/2025 12:05:42

Listen to the news

Gainers

Quoin Pharmaceuticals (NASDAQ:QNRX) stock moved upwards by 35.2% to $0.8 during Thursday's pre-market session. The market value of their outstanding shares is at $6.5 million.
Hepion Pharmaceuticals (NASDAQ:HEPA) shares rose 25.92% to $0.17. The company's market cap stands at $1.1 million.
Exicure (NASDAQ:XCUR) shares moved upwards by 23.52% to $12.81. The market value of their outstanding shares is at $38.9 million.
Vigil Neuroscience (NASDAQ:VIGL) stock rose 23.15% to $2.5. The market value of their outstanding shares is at $102.1 million.
TNF Pharmaceuticals (NASDAQ:TNFA) shares moved upwards by 17.54% to $1.34. The market value of their outstanding shares is at $3.6 million.
Inventiva (NASDAQ:IVA) shares moved upwards by 15.2% to $2.5. The company's market cap stands at $130.9 million.

Losers

Anitra (AMEX:AZTR) stock declined by 8.4% to $0.24 during Thursday's pre-market session. The market value of their outstanding shares is at $3.0 million.
Rigel Pharmaceuticals (NASDAQ:RIGL) stock declined by 7.62% to $20.15. The market value of their outstanding shares is at $354.9 million.
Eterna Therapeutics (NASDAQ:ERNA) shares fell 7.42% to $0.59. The company's market cap stands at $30.2 million.
Channel Therapeutics (AMEX:CHRO) shares declined by 7.04% to $2.51. The company's market cap stands at $15.1 million.
Zymeworks (NASDAQ:ZYME) stock declined by 6.62% to $13.7. The market value of their outstanding shares is at $947.5 million.
Elicio Therapeutics (NASDAQ:ELTX) stock declined by 6.43% to $6.99. The market value of their outstanding shares is at $75.4 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

FAQ

Fee Schedule Open Account Deposit & Withdrawal Trading

Terms & Conditions

Client Agreement Privacy Policy Data Disclaimer Security Tips

About Webull

About us Webull Promotions Contact information Announcements

Service Email : service@webull.hkBusiness Cooperation : marketinghk@webull.hk

Risk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
① During the campaign period, US stocks, US stocks short selling, US stock options, Hong Kong stocks, and A-shares trading will maintain at $0 commission, and no subscription/redemption fees for mutual fund transactions. $0 fee offer has a time limit, until further notice. For more information, please visit: https://www.webull.hk/pricing
② More than 40M Downloads Globally : data based on Webull Technologies Limited's internal statistics as of July 14, 2023.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.

Language

English